SCHEMBL30912043

CCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC

nearest known ligand 0.49

Predicted protein targets (top 14)

	gene	UniProt	supporting neighbours	confidence
▸	RXFP1	Q9HBX9	1/20	0.49

▸	GRIN2D	O15399	1/20	0.47

▸	GRIN3B	O60391	1/20	0.47

▸	GRIN1	Q05586	1/20	0.47

▸	GRIN2A	Q12879	1/20	0.47

▸	GRIN2B	Q13224	1/20	0.47

▸	GRIN2C	Q14957	1/20	0.47

▸	GRIN3A	Q8TCU5	1/20	0.47

▸	VIPR2	P41587	6/20	0.45

▸	VIPR1	P32241	4/20	0.45

▸	PTH1R	Q03431	4/20	0.43

▸	TASP1	Q9H6P5	1/20	0.43

▸	TFPI	P10646	1/20	0.42

▸	ENPEP	Q07075	3/20	0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30912044	0.95	RXFP1 (0.49)	RXFP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30912048	0.94	RXFP1 (0.50)	RXFP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30912041	0.93	RXFP1 (0.48)	RXFP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30483984	0.91	RXFP1 (0.46)	RXFP1VIPR2VIPR1TASP1ENPEP
SCHEMBL30912039	0.89	RXFP1 (0.50)	RXFP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30912040	0.89	RXFP1 (0.50)	RXFP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30912045	0.88	NPY4R (0.49)	RXFP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30912047	0.88	RXFP1 (0.49)	RXFP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30262186	0.87	VIPR2 (0.54)	RXFP1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30432907	0.86	VIPR1 (0.53)	GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240287153-A1	Treating Inflammatory Lung Disease	THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS	2024-08-29	—	—	US	disclosed
US-11993640-B2	Treating inflammatory lung disease	THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US)	2024-05-28	—	—	US	disclosed